top of page
Expertise
VIA Performance
eConsent Performance
73%
18%
9%
55%
18%
9%
9%
9%
18%
18%
9%
18%
37%
57%
43%
14%
14%
15%
43%
43%
14%
14%
15%
2024.03 Now
By Country
By Phase
By Therapeutic Area
By Country
By Phase
By Therapeutic Area
KOR
EU
JPN
Phase II
Phase III
OS/PMS
Medical Device
ETC.
Ophthalmology
Gastroenterology
Cardiovasular
Neurology
ETC.
KOR
JPN
IIT
Phase I
Phase III
Food & supplementary
Ophthalmology
Neurology
ETC.
Immunology
14%
14%
OS/PMS
Cardiovascular
Partnerships
Spero's business partners range from local and overseas clinical trial sponsors, pharmaceutical and medical device companies, to CROs and clinical research sites and centers
Key fields of cooperation
-
Clinical development operation (CRO service)
-
Patient recruitment service support
-
DCT solution operation support
Ophthanlmology
Gastroenterology
Endocrinology
Cardiovascular
Neurology
Others
15%
15%
15%
5%
15%
35%
Achievement
Spero started patient recruitment service in 2021 and has been accumulating achievements in various CRO service areas since it expanded its business to DCT in 2022.
Therapeutic Area & Phase
Experienced Staffs and Potential expertise
Spero is enhancing its expertise and operational efficiency for the successful execution of clinical trials
By Therapeutic area
By Phase
Others
Medical Device
IIT
OS
PMS
Phase IV
Phase I
Phase III
Phase II
5%
5%
15%
10%
50%
15%
Spero supports all phases of clinical trials, and prioritizes customer requirements, and the safety of clinical trials
Full Support Service
Clinical Operation
4%
4%
36%
44%
8%
4%
Statistics
Data Management
Medical Writing
Site Management
Project Management
Site Startup
By Operation service
bottom of page